Literature DB >> 22868753

Low-density crystal packing of human protein kinase CK2 catalytic subunit in complex with resorufin or other ligands: a tool to study the unique hinge-region plasticity of the enzyme without packing bias.

Karsten Klopffleisch1, Olaf-Georg Issinger, Karsten Niefind.   

Abstract

A low-resolution structure of the catalytic subunit CK2α of human protein kinase CK2 (formerly known as casein kinase 2) in complex with the ATP-competitive inhibitor resorufin is presented. The structure supplements previous human CK2α structures in which the interdomain hinge/helix αD region adopts a closed conformation correlating to a canonically established catalytic spine as is typical for eukaryotic protein kinases. In the corresponding crystal packing the hinge/helix αD region is nearly unaffected by crystal contacts, so that largely unbiased conformational adaptions are possible. This is documented by published human CK2α structures with the same crystal packing but with an open hinge/helix αD region, one of which has been redetermined here with a higher symmetry. An overview of all published human CK2α crystal packings serves as the basis for a discussion of the factors that determine whether the open or the closed hinge/helix αD conformation is adopted. Lyotropic salts in crystallization support the closed conformation, in which the Phe121 side chain complements the hydrophobic catalytic spine ensemble. Consequently, genuine ligand effects on the hinge/helix αD conformation can be best studied under moderate salt conditions. Ligands that stabilize either the open or the closed conformation by hydrogen bonds are known, but a general rule is not yet apparent.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22868753     DOI: 10.1107/S0907444912016587

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  8 in total

1.  Conformational flexibility of human casein kinase catalytic subunit explored by metadynamics.

Authors:  Aurélie Gouron; Anne Milet; Helene Jamet
Journal:  Biophys J       Date:  2014-03-04       Impact factor: 4.033

2.  Crystal structures of human CK2α2 in new crystal forms arising from a subtle difference in salt concentration.

Authors:  Masato Tsuyuguchi; Tetsuko Nakaniwa; Takayoshi Kinoshita
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2018-04-16       Impact factor: 1.056

3.  Unexpected Binding Mode of a Potent Indeno[1,2-b]indole-Type Inhibitor of Protein Kinase CK2 Revealed by Complex Structures with the Catalytic Subunit CK2α and Its Paralog CK2α'.

Authors:  Jennifer Hochscherf; Dirk Lindenblatt; Benedict Witulski; Robin Birus; Dagmar Aichele; Christelle Marminon; Zouhair Bouaziz; Marc Le Borgne; Joachim Jose; Karsten Niefind
Journal:  Pharmaceuticals (Basel)       Date:  2017-12-13

4.  Structural Hypervariability of the Two Human Protein Kinase CK2 Catalytic Subunit Paralogs Revealed by Complex Structures with a Flavonol- and a Thieno[2,3-d]pyrimidine-Based Inhibitor.

Authors:  Karsten Niefind; Nils Bischoff; Andriy G Golub; Volodymyr G Bdzhola; Anatoliy O Balanda; Andriy O Prykhod'ko; Sergiy M Yarmoluk
Journal:  Pharmaceuticals (Basel)       Date:  2017-01-11

5.  A π-Halogen Bond of Dibenzofuranones with the Gatekeeper Phe113 in Human Protein Kinase CK2 Leads to Potent Tight Binding Inhibitors.

Authors:  Alexander Schnitzler; Andreas Gratz; Andre Bollacke; Michael Weyrich; Uwe Kuckländer; Bernhard Wünsch; Claudia Götz; Karsten Niefind; Joachim Jose
Journal:  Pharmaceuticals (Basel)       Date:  2018-02-17

6.  Cell-based screen identifies a new potent and highly selective CK2 inhibitor for modulation of circadian rhythms and cancer cell growth.

Authors:  Tsuyoshi Oshima; Yoshimi Niwa; Keiko Kuwata; Ashutosh Srivastava; Tomoko Hyoda; Yoshiki Tsuchiya; Megumi Kumagai; Masato Tsuyuguchi; Teruya Tamaru; Akiko Sugiyama; Natsuko Ono; Norjin Zolboot; Yoshiki Aikawa; Shunsuke Oishi; Atsushi Nonami; Fumio Arai; Shinya Hagihara; Junichiro Yamaguchi; Florence Tama; Yuya Kunisaki; Kazuhiro Yagita; Masaaki Ikeda; Takayoshi Kinoshita; Steve A Kay; Kenichiro Itami; Tsuyoshi Hirota
Journal:  Sci Adv       Date:  2019-01-23       Impact factor: 14.136

Review 7.  Role of Computational Methods in Going beyond X-ray Crystallography to Explore Protein Structure and Dynamics.

Authors:  Ashutosh Srivastava; Tetsuro Nagai; Arpita Srivastava; Osamu Miyashita; Florence Tama
Journal:  Int J Mol Sci       Date:  2018-10-30       Impact factor: 5.923

8.  A representative of arylcyanomethylenequinone oximes effectively inhibits growth and formation of hyphae in Candida albicans and influences the activity of protein kinases in vitro.

Authors:  Maciej Masłyk; Monika Janeczko; Oleg M Demchuk; Anna Boguszewska-Czubara; Hieronim Golczyk; Anna Sierosławska; Anna Rymuszka; Aleksandra Martyna; Konrad Kubiński
Journal:  Saudi Pharm J       Date:  2017-12-05       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.